Ad71 s.r.o.
- Address
- Sudkova 2a/686, 109 00 Prague, Czechia
Ad71 s.r.o. - Neuropsychiatric Research Center
Ad71 s.r.o. is a specialized clinical research facility focused on advancing treatments for neurodegenerative and neuropsychiatric disorders. The center demonstrates particular expertise in Alzheimer's disease research across various stages and manifestations, from early cognitive impairment to complex neuropsychiatric symptoms. Their comprehensive approach encompasses both cognitive and behavioral aspects of neurological conditions, positioning them as a key contributor to understanding and treating progressive brain disorders.
- Alzheimer's disease spectrum disorders, including mild cognitive impairment (MCI), mild dementia, and Alzheimer's disease psychosis
- Novel therapeutic approaches including oral semaglutide, anti-inflammatory agents (XPro1595), and specialized treatments for neuropsychiatric symptoms (ACP-204)
- Major depressive disorder with focus on adjunctive antidepressant therapies and long-term safety evaluations
The research center's portfolio reflects a strong commitment to long-term safety and efficacy studies, conducting both placebo-controlled trials and open-label extension studies. Their work addresses critical unmet needs in treating cognitive decline, behavioral disturbances associated with dementia, and treatment-resistant depression, utilizing innovative biomarker-driven approaches to patient selection and outcome measurement.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Acadia Pharmaceuticals Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Acadia Pharmaceuticals Inc.2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ad71 s.r.o.
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of ACP-204 Tartrate in Adults with Alzheimer's Disease Psychosis: A Double-Blind, Placebo-Controlled Study | Acadia Pharmaceuticals Inc. | Phase II | Not Recruiting | Jul 2024 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acp-204 Tartrate | 2 | Unknown | 2024-07-02 | 2024-12-03 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.